These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 27704468)

  • 81. Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma.
    Jones CL; Degasperi A; Grandi V; Amarante TD; ; Mitchell TJ; Nik-Zainal S; Whittaker SJ
    Sci Rep; 2021 Feb; 11(1):3962. PubMed ID: 33597573
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Global Patterns of Methylation in Sézary Syndrome Provide Insight into the Role of Epigenetics in Cutaneous T-Cell Lymphoma.
    Whittaker S
    J Invest Dermatol; 2016 Sep; 136(9):1753-1754. PubMed ID: 27542296
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Targeted killing of TNFR2-expressing tumor cells and T
    Torrey H; Khodadoust M; Tran L; Baum D; Defusco A; Kim YH; Faustman DL
    Leukemia; 2019 May; 33(5):1206-1218. PubMed ID: 30356161
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A case of erythrodermic-CTCL.
    Shimoda T; Aoki M; Takezaki S; Futagami A; Inokuchi K; Sugisaki Y; Kawana S
    Leuk Lymphoma; 2006 Aug; 47(8):1708-10. PubMed ID: 16966295
    [No Abstract]   [Full Text] [Related]  

  • 85. Sézary Syndrome: Translating Genetic Diversity into Personalized Medicine.
    Chevret E; Merlio JP
    J Invest Dermatol; 2016 Jul; 136(7):1319-1324. PubMed ID: 27342034
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cutaneous T-cell lymphoma.
    Kotz EA; Anderson D; Thiers BH
    J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):131-7. PubMed ID: 12705741
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Single-cell analysis of Sézary syndrome reveals novel markers and shifting gene profiles associated with treatment.
    Borcherding N; Severson KJ; Henderson N; Ortolan LS; Rosenthal AC; Bellizzi AM; Liu V; Link BK; Mangold AR; Jabbari A
    Blood Adv; 2023 Feb; 7(3):321-335. PubMed ID: 35390145
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity.
    Poglio S; Prochazkova-Carlotti M; Cherrier F; Gros A; Laharanne E; Pham-Ledard A; Beylot-Barry M; Merlio JP
    Leukemia; 2021 Jun; 35(6):1696-1709. PubMed ID: 33106625
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome.
    Vadivel CK; Willerslev-Olsen A; Namini MRJ; Zeng Z; Yan L; Danielsen M; Gluud M; Pallesen EMH; Wojewoda K; Osmancevic A; Hedebo S; Chang YT; Lindahl LM; Koralov SB; Geskin LJ; Bates SE; Iversen L; Litman T; Bech R; Wobser M; Guenova E; Kamstrup MR; Ødum N; Buus TB
    Blood; 2024 Apr; 143(15):1496-1512. PubMed ID: 38170178
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Abatement of Sézary syndrome lesions following treatment with acyclovir.
    Scheman AJ; Steinberg I; Taddeini L
    Am J Med; 1986 Jun; 80(6):1199-202. PubMed ID: 2942033
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Single-cell analyses reveal novel molecular signatures and pathogenesis in cutaneous T cell lymphoma.
    Xue X; Wang Z; Mi Z; Liu T; Wang C; Shi P; Sun L; Yang Y; Li W; Wang Z; Liu H; Zhang F
    Cell Death Dis; 2022 Nov; 13(11):970. PubMed ID: 36400759
    [TBL] [Abstract][Full Text] [Related]  

  • 92. T-cell Lymphoma Epidemiology: the Known and Unknown.
    Phan A; Veldman R; Lechowicz MJ
    Curr Hematol Malig Rep; 2016 Dec; 11(6):492-503. PubMed ID: 27995419
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Restoration of peripheral blood T cell repertoire complexity during remission in advanced cutaneous T cell lymphoma.
    Yamanaka K; Fuhlbrigge RC; Mizutani H; Kupper TS
    Arch Dermatol Res; 2010 Aug; 302(6):453-9. PubMed ID: 20111968
    [TBL] [Abstract][Full Text] [Related]  

  • 94.
    Rassek K; Iżykowska K; Żurawek M; Pieniawska M; Nowicka K; Zhao X; Przybylski GK
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834942
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sézary syndrome.
    Anzengruber F; Ignatova D; Schlaepfer T; Chang YT; French LE; Pascolo S; Contassot E; Bobrowicz M; Hoetzenecker W; Guenova E
    Leuk Lymphoma; 2019 Aug; 60(8):1899-1907. PubMed ID: 30638415
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Malignant TOXication of T cells.
    Odum N
    Blood; 2015 Feb; 125(9):1361-2. PubMed ID: 25721042
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Sézary syndrome: diagnosis, prognosis, and critical review of treatment options.
    Wieselthier JS; Koh HK
    J Am Acad Dermatol; 1990 Mar; 22(3):381-401. PubMed ID: 2138177
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Single-cell heterogeneity in Sézary syndrome.
    Buus TB; Willerslev-Olsen A; Fredholm S; Blümel E; Nastasi C; Gluud M; Hu T; Lindahl LM; Iversen L; Fogh H; Gniadecki R; Litvinov IV; Persson JL; Bonefeld CM; Geisler C; Christensen JP; Krejsgaard T; Litman T; Woetmann A; Ødum N
    Blood Adv; 2018 Aug; 2(16):2115-2126. PubMed ID: 30139925
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Therapy of Sézary syndrome by extracorporeal photochemotherapy].
    Bohmeyer J; Otte HG; Stadler R
    Hautarzt; 1996 Jan; 47(1):24-8. PubMed ID: 8835000
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Novel therapeutic strategies for cutaneous T-cell lymphoma in advanced stages.
    Kun L; Hernandez-Ilizaliturri FJ; Reddy NM
    Semin Hematol; 2014 Jan; 51(1):35-41. PubMed ID: 24468314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.